Re-engineering Affordable Care Policy in China: Is Marketization a Solution? - Peter Nan-shong Lee - cover
Re-engineering Affordable Care Policy in China: Is Marketization a Solution? - Peter Nan-shong Lee - cover
Dati e Statistiche
Salvato in 0 liste dei desideri
Re-engineering Affordable Care Policy in China: Is Marketization a Solution?
Disponibilità in 2 settimane
81,40 €
81,40 €
Disponibilità in 2 settimane

Descrizione


Presenting a comprehensive examination of China’s medical care system, this book tackles issues of policymaking, organization, management and financing in the context of the provision of affordable care in China. Making use of extensive field investigations, interviews and a thorough analysis of documents, this book examines the re-structuring of the medical care system, spanning more than three and half decades from 1979 to the present day. Assessing the difficulties of regulatory control in the health care sector, it also explores theoretical alternatives, including post-Weberian constructs of uncertainty and control, as well as franchise and asymmetric information in market transactions. Ultimately, it argues that patient medical care has become less and less affordable amid shrinking government subsidies, breakdowns of public insurances and increases in user charges, especially between the mid-1990s and mid-2000s. Whilst the government took decades to re-organize the public hospital system and rebuild public insurances, it faced a dilemma of enforcing both low-cost medical care and maintaining revenue flow to public hospitals through marketization. Re-engineering Affordable Care Policy in China provides extensive discussion of the policymaking process as well as detailed analysis of policy contents. As such, it will be invaluable to students and scholars of Chinese social policy and public administration, as well as Chinese Studies more generally.

Dettagli

Testo in English
234 x 156 mm
453 gr.
9780367663339
Informazioni e Contatti sulla Sicurezza dei Prodotti

Le schede prodotto sono aggiornate in conformità al Regolamento UE 988/2023. Laddove ci fossero taluni dati non disponibili per ragioni indipendenti da Feltrinelli, vi informiamo che stiamo compiendo ogni ragionevole sforzo per inserirli. Vi invitiamo a controllare periodicamente il sito www.bianalisi.live per eventuali novità e aggiornamenti.
Per le vendite di prodotti da terze parti, ciascun venditore si assume la piena e diretta responsabilità per la commercializzazione del prodotto e per la sua conformità al Regolamento UE 988/2023, nonché alle normative nazionali ed europee vigenti.

Per informazioni sulla sicurezza dei prodotti, contattare productsafety@feltrinelli.it